Mostrar el registro sencillo del ítem

Artículo

dc.creatorSánchez-Torrijos, Yolandaes
dc.creatorAmpuero Herrojo, Javieres
dc.creatorPérez Palacios, Domingoes
dc.creatorGallego Durán, Rocíoes
dc.creatorRomero Gómez, Manueles
dc.date.accessioned2021-05-26T10:41:41Z
dc.date.available2021-05-26T10:41:41Z
dc.date.issued2019
dc.identifier.citationSánchez-Torrijos, Y., Ampuero Herrojo, J., Pérez Palacios, D., Gallego-Durán, R. y Romero Gómez, M. (2019). Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria. Revista Española de Enfermedades Digestivas, 111 (4), 270-274.
dc.identifier.issn1130-0108es
dc.identifier.urihttps://hdl.handle.net/11441/110820
dc.description.abstractAim: to assess the prevalence of non-alcoholic fatty liver disease (NAFLD) in the gastroenterology outpatient clinic and describe the use of the resources accordingly. Methods: a prospective and observational study of 403 patients seen in the gastroenterology outpatient clinic to rule out liver disease during three randomized months in 2016. The overall prevalence of NAFLD, disease severity, heterogeneity of the final diagnosis, the use of medical resources and their respective cost were analyzed. Results: the main reason for consultation was hypertransaminasemia (42.9%, 173/403), followed by hepatitis C virus (HCV) (28.5%, 115/403). NAFLD was identified as the definitive diagnosis in 29.8% (120/403) of the cohort, 69.2% (83/120) derived by hypertransaminasemia and 24.2% (29/120) by steatosis. Laboratory tests were performed in 96.7% (116/120), abdominal ultrasound in 88.3% (106/120), viral serology in 79.2%(95/120) and autoimmunity in 70% (84/120) of patients with NAFLD. Liver fibrosis was not assessed in 87.5% of cases. In a post-hoc analysis, 12.1% (17/120) had advanced fibrosis by FIB-4. On ultrasound, 65% (73/106) had hepatic steatosis and 15% (17/106) chronic liver disease (significant fibrosis). The mean time for diagnosis was 2.23 ± 0.8 visits. The terminology used to define the clinical diagnosis was heterogeneous as follows: a) 48.3% (58/120) hepatic steatosis; b) 15% (18/120) non-alcoholic steatohepatitis; c) 15.8% (19/120) fatty liver; d) 13.3% (16/120) metabolic syndrome; and e) 7.5% (9/120) dual liver disease (fatty liver and alcohol). A pharmacological intervention was performed in six patients, a liver biopsy in two patients and another six were referred to another specialist. The average cost per patient until diagnosis was €570.78, which included analytical, autoantibodies, viral serology and abdominal ultrasound, with a mean of 2.5 consultations. Thus, the total expense in patients with NAFLD was €68,493.6. Conclusion: NAFLD is a frequent cause of hypertransaminasemia. However, the heterogeneity in the management and terminology of the disease makes it necessary to initiate medical training actions in order to unify the criteria for disease control.es
dc.formatapplication/pdfes
dc.format.extent5es
dc.language.isoenges
dc.publisherSociedad Española de Patología Digestivaes
dc.relation.ispartofRevista Española de Enfermedades Digestivas, 111 (4), 270-274.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectNon-alcoholic fatty liver diseasees
dc.subjectNon-alcoholic steatohepatitises
dc.titleAnalysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteriaes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.identifier.doi10.17235/reed.2019.6088/2018es
dc.contributor.groupUniversidad de Sevilla. CTS-532: Unidad de Hepatologíaes
dc.journaltitleRevista Española de Enfermedades Digestivases
dc.publication.volumen111es
dc.publication.issue4es
dc.publication.initialPage270es
dc.publication.endPage274es

FicherosTamañoFormatoVerDescripción
Analysis of the burden and ...1.164MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional